查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011852

一次性生物製程市场：2026-2032年全球市场预测（按产品、工作流程阶段、生物製程方法、一次性子组件、製造流程、应用和最终用户划分）

Single-use Bioprocessing Market by Offering, Workflow Stage, Bioprocess Mode, Single-use Subassemblies, Manufacturing Processes, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，一次性生物製程市场价值将达到 208.1 亿美元，到 2026 年将成长至 241.1 亿美元，到 2032 年将达到 597.7 亿美元，年复合成长率为 16.26%。

主要市场统计数据
基准年 2025 208.1亿美元
预计年份：2026年 241.1亿美元
预测年份 2032 597.7亿美元
复合年增长率 (%) 16.26%

概述影响全球生物製造领导者策略决策的一次性生物製程技术和市场动态。

一次性生物製程已从实验性方法发展成为生物製药研发和商业化生产的核心製造模式。近年来，技术的进步、一次性技术的监管核准以及营运重点的转变，都提高了研发人员、合约服务供应商和大型製药企业对一次性製程的兴趣。本文说明了一次性系统如今的重要性：它们可以降低交叉污染的风险，缩短宣传活动週期，并提供模组化设计以支援灵活的生产结构。

数位整合、模组化设计和永续性倡议：正在重塑一次性生物製程。

一次性生物製程领域正经历着一场变革性的转型，其驱动力来自技术、监管和商业性等多面向因素。材料科学的进步和感测器的微型化提高了一次性组件的可靠性和分析能力，从而实现了更精确的製程控制和可重复的结果。同时，连接性的提升、嵌入式探针的引入以及透过远端监控实现的数位化集成，使得一次性系统能够与现代自动化框架相容，降低了其在受监管生产环境中的准入门槛。

对 2025 年美国预期关税措施将如何影响一次性生物加工的整个供应链、筹资策略和成本结构进行全面评估。

美国预计将于2025年实施的关税措施和贸易政策调整可能会影响筹资策略和库存管理，并对一次性产品的整个供应链产生连锁反应，但不会改变一次性产品的基本价值提案。关税带来的成本压力可能促使製造商重新评估其供应商多元化策略，尽可能优先考虑国内采购，并协商签订更长期的供应合约以降低价格波动。这些调整可能会影响前置作业时间，并促使企业更加重视对二级供应商进行认证，以确保供应的连续性。

详细的細項分析揭示了产品、工作流程、应用程式和最终用户之间的差异，从而确定采购、部署和创新重点。

了解需求和部署模式需要采用精细化的细分方法，将产品、工作流程、应用和最终用户与采购和技术优先顺序相匹配。从产品角度来看，生物反应器、层析法系统、过滤系统以及混合、储存和填充系统等设备和工厂是资本投资和整合规划的核心。生物反应器的容量选择，从 1000 公升到 1001 公升、2000 公升，甚至更大，都会影响製程设计和供应链的复杂性。除了诸如袋子、探针和感测器以及采样系统等简单和周边元件外，管道、过滤器、连接器和传输系统对于运行可靠性也至关重要，其中探针和感测器涵盖电导率、流速、氧气、pH 值、压力和温度的测量。细胞培养系统和注射器等运作设备类别有其自身的采购週期和验证路径，这些流程与设施设计选择密切相关。

从美洲、欧洲、中东和非洲以及亚太地区，详细分析了采用趋势、法规环境和产能趋势的区域观点。

区域趋势对产品应用、监管和供应链设计的影响方式截然不同，这要求企业主管根据每个地理丛集的具体情况调整策略。在美洲，强大的契约製造网络、成熟的法规结构以及生物技术丛集的集中，正推动一次性产品在临床和商业生产中的快速普及。北美企业往往优先考虑快速的临床部署和与供应商的整合关係，更倾向于选择能够提供承包系统和验证支援的供应商。

全面概述竞争格局，重点在于推动创新、伙伴关係和产业重组的关键製造商、系统整合商和服务供应商。

一次性生物製程领域的竞争格局呈现出持续性，涵盖了从专业元件供应商到全方位系统整合商和服务供应商的各个环节。领先的仪器製造商持续投资于稳健的抛弃式平台，不断扩展感测器和分析功能，以满足对製程可视性和法规遵循的需求。同时，越来越多的利基供应商专注于高性能耗材，例如一次性过滤、专用连接器和先进的管路材料。这些公司凭藉技术差异化和与现有系统的兼容性检验竞争。

为行业领导者提供切实可行的策略建议，以优化其供应链、加快采用速度并调整其经营模式，以适应不断变化的一次性使用趋势。

领导企业应采取平衡策略，既保持柔软性，又确保供应连续性，同时使技术选择与监管要求相符。这首先需要建立一个跨职能的管治结构，整合采购、品质、工程和营运部门，并对一次性部署决策进行全面评估。此管治结构应明确供应商认证标准、变更管理触发机制以及关键零件的紧急时应对计画，以降低意外中断的风险。

方法论概述，解释了支持本报告研究结果的主要和次要研究方法、检验方法和分析框架。

本研究采用综合分析方法，结合一手访谈、供应商和最终使用者画像以及严谨的二手资讯检验，确保分析结果反映实际情况。一手研究包括与来自不同组织的技术负责人、采购负责人和营运经理进行结构化讨论，以了解影响一次性部署的决策因素、挑战和实际应对措施。基于这些直接洞察，我们针对技术成熟度、供应链韧性和监管考量进行了主题分析。

在不断发展的单次使用生物製程系统中，策略挑战和营运经验的果断整合将指导经营团队决策。

总之，经营团队面临的挑战显而易见。一次性生物製程是一种极具吸引力的解决方案，它兼具操作柔软性、污染控制和模组化扩充性，但严格的供应商管治和系统化的规划对于充分发挥其潜力至关重要。成功实施此流程的公司透过结合技术评估、策略供应商合作和完善的验证体系，使其製程设计选择与监管要求和业务目标保持一致。结论部分总结了本报告的关键主题，并重点强调了为最有效地降低风险和加速实现效益而应优先采取的行动。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 一次性生物製程市场：依产品/服务分类

  • 各个部件
    • 袋子和容器
    • 连接器
    • 过滤和分离设备
    • 泵浦和流量控制
    • 采样装置及配件
    • 感测器和探头
    • 管子
      • 聚乙烯（PE）
      • 聚丙烯（PP）
      • 聚氯乙烯（PVC）
      • 硅酮
  • 一次性子组件
    • 生物反应器/製程组件
    • 培养基转移组件
    • 采样组件
    • 管路组件/歧管

第九章：一次性生物製程市场：各阶段工作流程

  • 下游工艺
  • 填充和表面处理工程
  • 品管/分析
  • 上游工程

第十章：以生物製程方法分類的一次性生物製程市场

  • 批次
  • 联邦批次
  • 灌注

第十一章 一次性生物製程市场（以一次性子组件划分）

  • 无菌转移套装
  • 填充子组件
  • 歧管组件
  • 取样子组件
  • 管组件

第十二章 按製造流程分類的一次性生物製程市场

  • 3D列印
  • 黏附
  • 吹塑成型
  • 挤压
  • 射出成型
  • 包覆成型
  • 高频焊接
  • 热成型
  • 超音波焊接

第十三章 一次性生物製程市场：依应用领域划分

  • 无菌灌装
  • 细胞培养
  • 过滤
  • 混合物
  • 纯化
  • 取样
  • 贮存

第十四章 一次性生物製程市场：依最终用户划分

  • 学术和研究机构
  • 契约製造组织（CMO）和受託研究机构（CRO）
  • 製药和生物技术公司

第十五章 一次性生物製程市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 一次性生物製程市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 一次性生物製程市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国一次性生物製程市场

第十九章：中国一次性生物製程市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvantaPure by NewAge Industries
  • Agilitech
  • Aseptic Group
  • Avantor, Inc.
  • Bionet Servicios Tecnicos SL
  • BioPharma Dynamics Ltd.
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Compagnie de Saint-Gobain
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Entegris, Inc.
  • Eppendorf SE
  • Foxx Life Sciences
  • Freudenberg Group
  • Getinge AB
  • Kuehne+Nagel International AG
  • Lonza Group AG Ltd.
  • Meissner Corporation
  • Merck KGaA
  • Mettler-Toledo International Inc.
  • Parker-Hannifin Corporation
  • PBS Biotech, Inc.
  • PharmNXT Biotech
  • PSG Dover by Dover Corporation
  • Repligen Corporation
  • SaniSure
  • Sartorius AG
  • Satake Multimix Corporation
  • Single Use Support GmbH
  • Tekni-Plex, Inc.
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
Product Code: MRR-431752EA4978

The Single-use Bioprocessing Market was valued at USD 20.81 billion in 2025 and is projected to grow to USD 24.11 billion in 2026, with a CAGR of 16.26%, reaching USD 59.77 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.81 billion
Estimated Year [2026] USD 24.11 billion
Forecast Year [2032] USD 59.77 billion
CAGR (%) 16.26%

Executive introduction to single-use bioprocessing technologies and market dynamics that frame strategic decisions for biomanufacturing leaders worldwide

Single-use bioprocessing has matured from an experimental approach into a core manufacturing paradigm for biologics development and commercial production. Over recent years, technological refinements, regulatory acceptance of disposable technologies, and shifting operational priorities have accelerated interest across developers, contract service providers, and established pharmaceutical manufacturers. This introduction outlines the context for why disposable systems matter now: they reduce cross-contamination risk, enable faster campaign turnaround, and offer modularity that supports flexible manufacturing footprints.

As organizations balance the need for speed with stringent quality controls, single-use solutions present trade-offs that require careful evaluation. Capital planning, material supply reliability, and integration with existing stainless-steel assets present practical considerations that shape implementation timelines. The introduction also previews themes that recur throughout the analysis, including lifecycle sustainability, digital instrumentation and sensors, fill-finish decentralization, and the evolving role of suppliers as system integrators rather than component vendors.

Readers will find that appreciating the technology not only in isolation but as part of a broader biomanufacturing ecosystem clarifies where value accrues and where risks remain. Subsequent sections build on this foundation by examining the transformative shifts driving adoption, the implications of changing trade policy, the nuanced segmentation of demand, and the regional and competitive dynamics executives must weigh when defining their single-use strategies.

Emerging technological and operational inflection points reshaping single-use bioprocessing including digital integration, modular design, and sustainability drivers

The single-use bioprocessing landscape is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces. Advances in materials science and sensor miniaturization have improved the reliability and analytics available within disposable assemblies, enabling closer process control and more reproducible outcomes. At the same time, digital integration-through improved connectivity, embedded probes, and remote monitoring-has made single-use systems compatible with modern automation frameworks, thus lowering the barrier to deployment in regulated production environments.

Operational models are also shifting. Manufacturers increasingly prefer modular, skidded solutions that can be scaled horizontally to meet variable demand rather than investing in large fixed-capacity stainless-steel facilities. This change supports fast product lifecycle transitions and contract manufacturing arrangements where rapid changeover and near-term flexibility matter most. Sustainability concerns and lifecycle assessment methodologies are placing new emphasis on material reuse where feasible, while also recognizing the energy and water savings that disposables can deliver over certain process footprints.

Moreover, supply chain resilience has moved to the top of procurement agendas. The industry is responding with supplier consolidation in some segments and with deeper partnerships in others, where vendors provide integrated systems, validation support, and inventory management services. These shifts create an imperative for biomanufacturers to reassess vendor selection criteria, governance models for technology transfer, and investment priorities that balance short-term agility with long-term operational continuity.

Comprehensive assessment of how United States tariff measures anticipated in 2025 could affect supply chains, sourcing strategies, and cost structures across single-use bioprocessing

Anticipated tariff actions and trade policy adjustments in the United States for 2025 have the potential to reverberate through single-use supply chains, influencing sourcing strategies and inventory management without altering the underlying value proposition of disposables. Tariff-driven cost pressures can prompt manufacturers to revisit their vendor diversification strategies, prioritize domestic sourcing options where feasible, and negotiate longer-term supply agreements to smooth price volatility. These adjustments, in turn, can alter lead times and increase emphasis on qualification of secondary suppliers to preserve continuity.

Importantly, companies may respond by adapting procurement tactics: increasing local inventory buffers for critical components, shifting to suppliers with regional manufacturing footprints, or revising contracts to include price adjustment mechanisms tied to trade measures. Such tactical responses help reduce exposure but can increase working capital requirements and complicate logistics. Strategic responses can include investing in local assembly capability for critical subassemblies or deepening partnerships with suppliers who can provide dual-sourcing assurances and validated equivalents for proprietary materials.

Regulatory and compliance considerations also intersect with tariff responses. When sourcing shifts across borders, companies must ensure that material traceability, certificate of analysis requirements, and change control procedures remain robust. Firms that proactively align their supply chain governance with expected policy scenarios will maintain higher operational resilience and reduce the risk of production disruption. Ultimately, while tariffs influence cost structures and sourcing choices, the most successful organizations will treat trade measures as one variable within a broader resilience and supplier management strategy.

Deep segmentation intelligence revealing product, workflow, application, and end-user distinctions that determine procurement, deployment, and innovation priorities

Understanding demand and deployment patterns requires a nuanced segmentation approach that aligns products, workflows, applications, and end users with procurement and technical priorities. From a product perspective, apparatus and plants including bioreactors, chromatography systems, filtration systems, mixing, storage, and filling systems occupy the core of capital and integration planning; bioreactor sizing choices from up to 1000L through 1001L to 2000L and above 2000L influence process design and supply chain complexity. Simple and peripheral elements such as bags, probes and sensors, sampling systems, along with tubing, filters, connectors, and transfer systems are essential to operational reliability, with probes and sensors covering conductivity, flow, oxygen, pH, pressure, and temperature measurement. Work equipment categories such as cell culture systems and syringes present their own procurement cycles and validation pathways that intersect with facility design choices.

When viewed through the lens of workflow stage, distinctions between upstream processing, downstream processing, fill-finish operations, and quality control and analytics determine how organizations allocate capital and technical resources. Upstream decisions often drive requirements for containment, sterility, and sensor integration, while downstream choices emphasize purification capacity and single-use chromatography and filtration consumables. Fill-finish operations necessitate robust aseptic strategies and equipment compatibility with closed-system disposables, and quality control workflows require validated sampling, analytics, and traceability to meet regulatory expectations.

Application-driven segmentation further refines priorities: aseptic filling, cell culture growth, filtration, mixing, purification, sampling, and storage each impose distinct demands on materials, compatibility testing, and operator training. End users, ranging from academic and research institutes to contract manufacturing and research organizations, as well as pharmaceutical and biotechnology companies, approach adoption with differing risk profiles, validation capabilities, and budgetary constraints. Together, these segmentation axes reveal where suppliers should focus product development, how integrators should configure systems, and why purchasers must balance technical fit, regulatory readiness, and service commitments when selecting single-use solutions.

Granular regional perspectives on adoption trajectories, regulatory environments, and capacity trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption, regulation, and supply chain design in materially different ways, requiring executives to tailor strategies for each geographic cluster. In the Americas, strong contract manufacturing networks, a mature regulatory framework, and a concentration of biotech clusters drive rapid adoption of disposables for both clinical and commercial manufacturing. North American organizations tend to emphasize speed to clinic and integrated supplier relationships, which favors vendors offering turnkey systems and validation support.

Europe, Middle East & Africa presents a complex regulatory mosaic and a high focus on sustainability and lifecycle assessment. Regulatory stringency combined with heightened attention to environmental impact pushes stakeholders to evaluate trade-offs between disposables and reusable systems, often prompting hybrid approaches that pair disposables with centralized utilities and waste management strategies. The region also demonstrates active public-private initiatives to bolster manufacturing resilience and to expand local capability in advanced therapies.

Asia-Pacific exhibits diverse adoption patterns driven by rapid capacity expansion, government-supported biomanufacturing initiatives, and a growing base of contract manufacturers. Increasing investment into local production and the desire to shorten supply chains encourage partnerships with suppliers capable of regional manufacturing or local assembly to meet throughput and qualification timelines. Across all regions, regulatory harmonization efforts and cross-border supply chain planning remain pivotal to scaling single-use deployments efficiently.

Competitive landscape synthesis highlighting leading manufacturers, system integrators, and service providers driving innovation, partnerships, and consolidation dynamics

Competitive dynamics in single-use bioprocessing reflect a continuum from specialized component suppliers to full-scope systems integrators and service providers. Leading equipment manufacturers continue to invest in robust disposable platforms while expanding sensor and analytics capabilities to meet demand for process visibility and regulatory compliance. At the same time, a growing number of niche suppliers focus on high-performance consumables such as single-use filtration media, specialized connectors, and advanced tubing materials; these firms compete on technical differentiation and validated compatibility with legacy systems.

Service providers and contract organizations increasingly participate in the value chain by offering validation support, inventory management, and assembly services that reduce purchaser burden. This trend blurs traditional supplier-customer boundaries as companies seek bundled offerings that include installation, training, and lifecycle support. Partnerships and strategic alliances are common, with technology cross-licensing and co-development agreements accelerating time-to-market for integrated solutions.

The fastest-moving companies combine engineering excellence with an ability to support regulatory submissions and supply continuity. Firms that can demonstrate rigorous quality systems, documented traceability, and robust after-sales service establish durable commercial relationships. For purchasers, assessing supplier capability now requires evaluating not only product performance but also the supplier's global footprint, validation toolkits, and readiness to support multi-site deployments over extended product lifecycles.

Actionable strategic recommendations for industry leaders to optimize supply chains, accelerate adoption, and align commercial models with evolving single-use dynamics

Leaders should pursue a balanced approach that preserves flexibility, ensures supply continuity, and aligns technical choices with regulatory obligations. Begin by establishing cross-functional governance that brings together procurement, quality, engineering, and operations to evaluate single-use adoption decisions holistically. This governance should codify supplier qualification criteria, change-control triggers, and contingency plans for critical components to reduce the risk of unexpected disruptions.

Next, prioritize dual-sourcing and regional supplier relationships where feasible to mitigate trade and logistic exposures while negotiating long-term commitments that include service-level expectations and validation artifacts. Invest in internal capabilities for integration and qualification so that partner handoffs do not become bottlenecks; organizations that develop in-house expertise in single-use assembly, cleaning of shared utilities, and analytics will shorten deployment cycles and reduce external dependency.

Finally, integrate sustainability and lifecycle analysis into procurement decisions to identify where disposables demonstrably reduce energy, water, or contamination risk, and where hybrid models provide the best total impact. Encourage suppliers to provide detailed material declarations and end-of-life handling programs, and embed those considerations into capital planning and vendor scorecards to drive continuous improvement across the supply base.

Methodological overview explaining primary and secondary research approaches, validation techniques, and analytical frameworks that underpin the report's findings

The research synthesis relies on a mixed-methods approach combining primary interviews, supplier and end-user profiling, and rigorous secondary-source validation to ensure the analysis reflects operational realities. Primary research involved structured discussions with technical leaders, procurement heads, and operations managers across a range of organizations to capture decision drivers, pain points, and practical workarounds that influence single-use adoption. These firsthand insights anchored thematic analysis around technology readiness, supply chain resilience, and regulatory considerations.

Secondary research included targeted reviews of technical literature, standards publications, and regulatory guidance documents to validate technical claims and to map common qualification pathways. Data triangulation and cross-validation steps ensured that reported trends represent broad industry sentiment rather than isolated experiences. The methodology also applied scenario analysis to examine how sourcing, tariff, and regional variables interact with operational priorities, while preserving confidentiality and anonymization for all contributing interviewees.

Quality assurance processes encompassed peer review by subject-matter experts and a final editorial pass focusing on technical accuracy and clarity. The resulting analytical framework supports decision-makers by linking strategic imperatives to operational actions and by providing a reproducible basis for internal benchmarking and supplier evaluation exercises.

Conclusive synthesis of strategic imperatives and operational takeaways to guide executive decisions in the evolving single-use bioprocessing ecosystem

In closing, the imperative for executives is clear: single-use bioprocessing presents a compelling mix of operational flexibility, contamination control, and modular scalability, yet it requires disciplined supplier governance and systemic planning to realize its potential. Successful adopters couple technological evaluation with strategic supplier engagement and robust validation frameworks, thereby aligning process design choices with regulatory and business objectives. The conclusion consolidates the report's central themes and reinforces the priority actions that will most effectively reduce risk and accelerate benefit realization.

As organizations refine their approach to single-use systems, attention to supply chain resilience, regional regulatory nuance, and integrated service offerings will distinguish leaders from followers. Executives should treat the transition to disposables as a programmatic change that spans procurement, quality, engineering, and sustainability agendas rather than a series of isolated purchases. With thoughtful planning and targeted investment in people and processes, the operational advantages of single-use technologies can be achieved while maintaining compliance, predictability, and cost discipline.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single-use Bioprocessing Market, by Offering

  • 8.1. Individual Components
    • 8.1.1. Bags & Containers
    • 8.1.2. Connectors
    • 8.1.3. Filtration & Separation Devices
    • 8.1.4. Pumps & Flow Control
    • 8.1.5. Sampling Devices & Accessories
    • 8.1.6. Sensors & Probes
    • 8.1.7. Tubing
      • 8.1.7.1. Polyethylene (PE)
      • 8.1.7.2. Polypropylene (PP)
      • 8.1.7.3. Polyvinyl Chloride (PVC)
      • 8.1.7.4. Silicone
  • 8.2. Single-Use Subassemblies
    • 8.2.1. Bioreactor / Process Assemblies
    • 8.2.2. Media Transfer Assemblies
    • 8.2.3. Sampling Assemblies
    • 8.2.4. Tubing Assemblies / Manifolds

9. Single-use Bioprocessing Market, by Workflow Stage

  • 9.1. Downstream Processing
  • 9.2. Fill-Finish Operations
  • 9.3. Quality Control & Analytics
  • 9.4. Upstream Processing

10. Single-use Bioprocessing Market, by Bioprocess Mode

  • 10.1. Batch
  • 10.2. Fed-Batch
  • 10.3. Perfusion

11. Single-use Bioprocessing Market, by Single-use Subassemblies

  • 11.1. Aseptic Transfer Sets
  • 11.2. Filling Subassemblies
  • 11.3. Manifold Assemblies
  • 11.4. Sampling Subassemblies
  • 11.5. Tubing Assemblies

12. Single-use Bioprocessing Market, by Manufacturing Processes

  • 12.1. 3D Printing
  • 12.2. Adhesive Bonding
  • 12.3. Blow Molding
  • 12.4. Extrusion
  • 12.5. Injection Molding
  • 12.6. Overmolding
  • 12.7. RF Welding
  • 12.8. Thermoforming
  • 12.9. Ultrasonic Welding

13. Single-use Bioprocessing Market, by Application

  • 13.1. Aseptic Filling
  • 13.2. Cell Culture
  • 13.3. Filtration
  • 13.4. Mixing
  • 13.5. Purification
  • 13.6. Sampling
  • 13.7. Storage

14. Single-use Bioprocessing Market, by End User

  • 14.1. Academic & Research Institutes
  • 14.2. Contract Manufacturing Organizations & Contract Research Organizations
  • 14.3. Pharmaceutical & Biotechnology Companies

15. Single-use Bioprocessing Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Single-use Bioprocessing Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Single-use Bioprocessing Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Single-use Bioprocessing Market

19. China Single-use Bioprocessing Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AdvantaPure by NewAge Industries
  • 20.6. Agilitech
  • 20.7. Aseptic Group
  • 20.8. Avantor, Inc.
  • 20.9. Bionet Servicios Tecnicos SL
  • 20.10. BioPharma Dynamics Ltd.
  • 20.11. CellBios Healthcare & Lifesciences Pvt. Ltd.
  • 20.12. Compagnie de Saint-Gobain
  • 20.13. Corning Incorporated
  • 20.14. Cytiva by Danaher Corporation
  • 20.15. Entegris, Inc.
  • 20.16. Eppendorf SE
  • 20.17. Foxx Life Sciences
  • 20.18. Freudenberg Group
  • 20.19. Getinge AB
  • 20.20. Kuehne + Nagel International AG
  • 20.21. Lonza Group AG Ltd.
  • 20.22. Meissner Corporation
  • 20.23. Merck KGaA
  • 20.24. Mettler-Toledo International Inc.
  • 20.25. Parker-Hannifin Corporation
  • 20.26. PBS Biotech, Inc.
  • 20.27. PharmNXT Biotech
  • 20.28. PSG Dover by Dover Corporation
  • 20.29. Repligen Corporation
  • 20.30. SaniSure
  • 20.31. Sartorius AG
  • 20.32. Satake Multimix Corporation
  • 20.33. Single Use Support GmbH
  • 20.34. Tekni-Plex, Inc.
  • 20.35. Thermo Fisher Scientific Inc.
  • 20.36. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONNECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONNECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONNECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION & SEPARATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION & SEPARATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION & SEPARATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS & FLOW CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS & FLOW CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS & FLOW CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING DEVICES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING DEVICES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING DEVICES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SENSORS & PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SENSORS & PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SENSORS & PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYETHYLENE (PE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYETHYLENE (PE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTOR / PROCESS ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTOR / PROCESS ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTOR / PROCESS ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA TRANSFER ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA TRANSFER ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA TRANSFER ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES / MANIFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES / MANIFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES / MANIFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC TRANSFER SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC TRANSFER SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC TRANSFER SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILLING SUBASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILLING SUBASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILLING SUBASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANIFOLD ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANIFOLD ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANIFOLD ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SUBASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SUBASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SUBASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ADHESIVE BONDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ADHESIVE BONDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ADHESIVE BONDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OVERMOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OVERMOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OVERMOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY RF WELDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY RF WELDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY RF WELDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY THERMOFORMING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY THERMOFORMING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ULTRASONIC WELDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ULTRASONIC WELDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ULTRASONIC WELDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 259. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 261. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 266. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 292. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 294. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 295. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 296. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 298. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 299. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 303. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING,